SuperworthKyntra Bio shares outstanding KYNB
Diluted shares outstanding, averaged over each quarter, from 2014.
- Latest quarter, to Jun 30, 2026
- 4M
- On a year earlier
- +0.1%
- more shares
Kyntra Bio had 4M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is about the same as a year earlier.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 4M | +0% |
| FY2024 | 4M | +2% |
| FY2023 | 3.9M | +5% |
| FY2022 | 3.8M | +1% |
| FY2021 | 3.7M | +2% |
| FY2020 | 3.6M | +4% |
| FY2019 | 3.5M | +3% |
| FY2018 | 3.4M | +4% |
| FY2017 | 3.3M | +30% |
| FY2016 | 2.5M | +3% |
| FY2015 | 2.5M | +77% |
| FY2014 | 1.4M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 4M | +0% | |
| Q1 FY26 | 4M | +0% | |
| Q4 FY25 | 4M | +0% | |
| Q3 FY25 | 4M | +1% | |
| Q2 FY25 | 4M | +1% | |
| Q1 FY25 | 4M | +2% | |
| Q4 FY24 | 4M | +2% | |
| Q3 FY24 | 4M | +2% | |
| Q2 FY24 | 4M | +2% | |
| Q1 FY24 | 4M | +5% | |
| Q4 FY23 | 3.9M | +5% | |
| Q3 FY23 | 3.9M | +5% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Kyntra Bio
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.